Reumatoloxía

2018

1. 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension

   Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 6, pp. 870-876

2. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

   Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 476-479

3. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients

   Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 1, pp. 22-27

4. Adipokines and inflammation: is it a question of weight?

   British Journal of Pharmacology, Vol. 175, Núm. 10, pp. 1569-1579

5. Administration of intra-articular hydrogen sulphide reduces the severity of osteoarthritis in vivo

   Boletín de la Sociedad Española de Hidrología Médica, Núm. 1, pp. 90-91

6. An educational environment based on digital image processing to support the learning process of biomaterials degradation in stem cells

   Proceedings of the 2018 IEEE 25th International Conference on Electronics, Electrical Engineering and Computing, INTERCON 2018

7. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: Multicentre retrospective study

   Rheumatology (United Kingdom), Vol. 57, Núm. 5, pp. 856-864

8. Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study

   Clinical and Experimental Rheumatology, Vol. 36, Núm. 3, pp. 0382-0388

9. Association of General and Abdominal Obesity With Hypertension, Dyslipidemia and Prediabetes in the PREDAPS Study

   Revista Espanola de Cardiologia, Vol. 71, Núm. 3, pp. 170-177

10. Biologic Disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 ACORDAR project

    Reumatologia Clinica, Vol. 14, Núm. 2, pp. 90-96

11. Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks

    Journal of Orthopaedic Research, Vol. 36, Núm. 2, pp. 594-604

12. Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment

    RMD Open, Vol. 4, Núm. 1

13. Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

    RMD Open, Vol. 4, Núm. 2

14. Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology (Rheumatology International, (2018), 38, 3, (467-472), 10.1007/s00296-018-3930-7)

    Rheumatology International

15. Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (Rheumatology International, (2018), 38, 9, (1735-1740), 10.1007/s00296-018-4097-y)

    Rheumatology International

16. Corrigendum to “Overview of changes in RMD epidemiology and outcome development in the last 10 years” [Best Pract Res Clin Rheumatol 32 (2018)169–173](S1521694218300718)(10.1016/j.berh.2018.10.008)

    Best Practice and Research: Clinical Rheumatology

17. E74-Like Factor (ELF3) and Leptin, a Novel Loop between Obesity and Inflammation Perpetuating a Pro-Catabolic State in Cartilage

    Cellular Physiology and Biochemistry, Vol. 45, Núm. 6, pp. 2401-2410

18. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)

    Clinical Microbiology and Infection, Vol. 24, pp. S10-S20

19. Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: A phase IIIB, randomised controlled trial (ACTIVE)

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 5, pp. 690-698

20. Efectos anti-catabólicos del sulfuro de hidrógeno en tejido articular artrósico

    Boletín de la Sociedad Española de Hidrología Médica, Núm. 1, pp. 179-180